Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PHENAPHEN W CODEINE NO 2.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PHENAPHEN W CODEINE NO 2.
METHADOSE vs PHENAPHEN W/ CODEINE NO. 2
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Codeine is an opioid agonist with affinity for mu-opioid receptors, producing analgesia, cough suppression, and sedation. Acetaminophen is a centrally acting analgesic and antipyretic with unclear mechanism, possibly involving COX-2 inhibition and cannabinoid receptor activation.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
1-2 tablets (codeine 15-30 mg, acetaminophen 325-650 mg) every 4 hours as needed for pain; maximum: 12 tablets per day.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Phenacetin: terminal half-life ~0.5-2 hours (rapidly eliminated; active metabolite APAP has half-life ~2-3 hours). Codeine: terminal half-life ~2.5-4 hours (increased in CYP2D6 poor metabolizers). Acetaminophen: terminal half-life ~1.5-3 hours (prolonged in hepatic impairment or overdose). Clinical context: half-lives are shortened with chronic use due to autoinduction (phenacetin) and unchanged with therapeutic doses.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Phenacetin (active metabolite): renal elimination of conjugated metabolites, primarily as sulfate and glucuronide conjugates; ~60% renal. Codeine: ~90% renal, with 5-15% as free codeine, 10% as norcodeine, and 40-70% as conjugated morphine and norcodeine; ~10% fecal. Apap (acetaminophen): renal elimination of conjugated metabolites, with ~85% excreted in urine as sulfate and glucuronide conjugates, ~5% as unchanged drug, and <5% as cysteine/mercapturate conjugates.
Category C
Category D/X
Opioid Agonist
Opioid Agonist